Table 3 Co-variant patterns of different YMDD variant types and genotypes
From: Compensatory variances of drug-induced hepatitis B virus YMDD mutations
YIDD_A (53, 159, 180, 204, 207, 219) | YVDD_A (180,204) | YIDD_A (13,135,204,207,222,229,259,271,337) | YVDD_B (180,204) | YIDD_C (80,180,204) | YVDD_C (180,204) | YIDD_D (7,16,80,91,180,204,316) | YVDD_D (53,180,204,229) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TTMIIA | 40.0 % | MV | 98.5 % | LYIITFSLT | 57.1 % | MV | 92.3 % | IMI | 8.4 % | MV | 93.9 % | –TIIMI– | 29.7 % | DMVF | 69.2 % |
TTMIIA | 10.0 % | –V | 1.5 % | LYIIT–SLT | 8.6 % | –V | 7.7 % | VMI | 1.2 % | –V | 6.1 % | T–IIMIH | 25.7 % | DMV– | 3.8 % |
T–MIIA | 10.0 % | LYIMT–SLT | 2.9 % | I–I | 31.3 % | T–IIMI– | 8.1 % | –MV– | 26.9 % | ||||||
–TMIIA | 10.0 % | —I–TF—– | 2.9 % | –MI | 26.5 % | —I–MI– | 4.1 % | ||||||||
—MIIA | 10.0 % | —I–T—— | 22.9 % | V–I | 1.2 % | TT—–IH | 12.2 % | ||||||||
—MI–A | 10.0 % | —IM——– | 2.9 % | —I | 31.3 % | TT—–I– | 5.4 % | ||||||||
—–I— | 10.0 % | —I——— | 2.9 % | ——–I– | 1.4 % | ||||||||||